Allovir

Closed

Allovir is a biotech company in Waltham, United States, founded in 2013. It has raised $150.0M across 2 rounds, most recently a $120.0M Series B in May 2019.

Kalaris Therapeutics – Your vision, our mission

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$150.0M
Last Round
$120.0M Series BMay 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

AlloVir (formerly ViraCyte) was a clinical-stage biopharmaceutical company founded in 2013 out of Baylor College of Medicine's Center for Cell and Gene Therapy, headquartered in Waltham, Massachusetts. The company was the leader in developing allogeneic, off-the-shelf, multi-virus-specific T-cell therapies to restore natural immunity in immunocompromised patients against life-threatening viral diseases. AlloVir was an ElevateBio portfolio company and was publicly traded on Nasdaq. In November 2024, AlloVir and Kalaris Therapeutics announced a merger agreement, effectively ending AlloVir's independent operations.

Summary

It lists 51–200 employees. It has raised $150.0M in total across 2 rounds, most recently a $120.0M Series B round in May 2019. Investors include Gilead Sciences and F2 Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOAug 2020
$317.7M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allovir on Indexed.vc
<a href="https://indexed.vc/companies/allovir"><img src="https://indexed.vc/api/badge/company/allovir" alt="Allovir on Indexed.vc" width="260" height="76" /></a>